INVO Fertility (IVF) Return on Capital Employed Growth (3y) (2015 - 2026)
INVO Fertility (IVF) Return on Capital Employed Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -846.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1,318.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -247.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | INVO Fertility | 1,108.74 | -4.90 Mn | 732,978.00 | -41,380.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41,380.00 |
| Sep 30, 2025 | 11,461.00 |
| Jun 30, 2025 | -23,201.00 |
| Mar 31, 2025 | -26.00 |
| Dec 31, 2024 | -8,503.00 |
| Sep 30, 2024 | 18,607.00 |
| Jun 30, 2024 | 34,182.00 |
| Mar 31, 2024 | -3,122.00 |
| Dec 31, 2023 | 6,758.00 |
| Sep 30, 2023 | 377,404.00 |
| Jun 30, 2023 | 3.58 Mn |
| Mar 31, 2023 | -15,071.00 |
| Dec 31, 2022 | -137,257.00 |
| Sep 30, 2022 | -1,294.00 |
| Jun 30, 2022 | -2,725.00 |
| Mar 31, 2022 | -14,290.00 |
| Dec 31, 2021 | -16,698.00 |
| Sep 30, 2021 | -16,810.00 |
| Jun 30, 2021 | -13,139.00 |
| Mar 31, 2021 | -7,800.00 |